Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial-Reference-Cited by-同舟云学术

Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial

Published:2017-09-18 Issue:1 Volume:15 Page:178-189
ISSN:1933-7213
Container-title:Neurotherapeutics
language:en
Short-container-title:Neurotherapeutics

Author:

Bruna Jordi,Videla Sebastián,Argyriou Andreas A.,Velasco Roser,Villoria Jesús,Santos Cristina,Nadal Cristina,Cavaletti Guido,Alberti Paola,Briani Chiara,Kalofonos Haralabos P.,Cortinovis Diego,Sust Mariano,Vaqué Anna,Klein Thomas,Plata-Salamán Carlos

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Neurology (clinical),Pharmacology

Link

http://link.springer.com/article/10.1007/s13311-017-0572-5/fulltext.html

Reference33 articles.

1. Argyriou AA, Bruna J, Marmiroli P, Cavaletti G. Chemotherapy-induced peripheral neurotoxicity (CIPN): an update. Crit Rev Oncol Hematol 2012;82:51-77.

2. Andre T, Boni C, Navarro M, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 2009;27:3109-3116.

3. Mols F, Beijers T, Lemmens V, et al. Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry. J Clin Oncol 2013;31:2699-2707.

4. Sisignano M, Baron R, Scholich K, Geisslinger G. Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain. Nat Rev Neurol 2014;10:694-707.

5. Argyriou AA, Cavaletti G, Briani C, et al. Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer. Cancer 2013;119:438-444.

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy-Induced Peripheral Neuropathy: A Recent Update on Pathophysiology and Treatment;Life;2024-08-09

2. Preclinical Evaluation of Sigma 1 Receptor Antagonists as a Novel Treatment for Painful Diabetic Neuropathy;ACS Pharmacology & Translational Science;2024-07-18

3. Incidence and risk factors for developing chemotherapy‐induced neuropathic pain in 500 cancer patients: A file‐based observational study;Journal of the Peripheral Nervous System;2024-02-04

4. Thiophenpiperazine amide derivatives as new dual MOR and σ1R ligands for the treatment of pain;Biochemical and Biophysical Research Communications;2024-02

5. Advances in Cancer Pain Management;Handbook of Oncobiology: From Basic to Clinical Sciences;2024